Company registration number SC593120 (Scotland)
AESTHETICA (MEDICAL COSMETICS) LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
AESTHETICA (MEDICAL COSMETICS) LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 5
AESTHETICA (MEDICAL COSMETICS) LTD
STATEMENT OF FINANCIAL POSITION
AS AT
30 APRIL 2025
30 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Non-current assets
Intangible assets
-
0
-
0
Property, plant and equipment
3
82,736
79,064
Current assets
Inventories
2,608
4,954
Trade and other receivables
4
-
0
2,920
Cash and cash equivalents
35,413
20,053
38,021
27,927
Current liabilities
5
(60,174)
(47,051)
Net current liabilities
(22,153)
(19,124)
Total assets less current liabilities
60,583
59,940
Non-current liabilities
6
(31,917)
(17,417)
Net assets
28,666
42,523
Equity
Called up share capital
7
100
100
Retained earnings
28,566
42,423
Total equity
28,666
42,523

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 16 April 2026
Mrs C Williamson
Director
Company registration number SC593120 (Scotland)
AESTHETICA (MEDICAL COSMETICS) LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 2 -
1
Accounting policies
Company information

Aesthetica (Medical Cosmetics) Ltd is a private company limited by shares incorporated in Scotland. The registered office is 2, Melville Street, Falkirk, Scotland, FK1 1HZ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.3
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
Standard at 25%
Plant and equipment
Reducing balance at 25%
Fixtures and fittings
Reducing balance at 15%

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Inventories

Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition.

 

Inventories held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of inventories over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

AESTHETICA (MEDICAL COSMETICS) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.7
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
AESTHETICA (MEDICAL COSMETICS) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 4 -
3
Property, plant and equipment
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 May 2024
38,620
69,203
107,823
Additions
25,117
8,848
33,965
At 30 April 2025
63,737
78,051
141,788
Depreciation and impairment
At 1 May 2024
9,655
19,104
28,759
Depreciation charged in the year
15,934
14,359
30,293
At 30 April 2025
25,589
33,463
59,052
Carrying amount
At 30 April 2025
38,148
44,588
82,736
At 30 April 2024
28,965
50,099
79,064
4
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Trade receivables
-
0
201
Other receivables
-
0
2,719
-
0
2,920
5
Current liabilities
2025
2024
£
£
Bank loans
6,000
-
0
Trade payables
11,291
1,360
Taxation and social security
13,808
-
0
Other payables
29,075
45,691
60,174
47,051
AESTHETICA (MEDICAL COSMETICS) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 5 -
6
Non-current liabilities
2025
2024
£
£
Bank loans and overdrafts
20,000
-
0
Other payables
11,917
17,417
31,917
17,417
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
2025-04-302024-05-01falsefalsefalse16 April 2026CCH SoftwareCCH Accounts Production 2026.100The principal activity of the company continued to be that of specialist medical practice activities.
Mrs C Williamson
SC5931202024-05-012025-04-30SC5931202025-04-30SC5931202024-04-30SC593120core:LandBuildings2025-04-30SC593120core:OtherPropertyPlantEquipment2025-04-30SC593120core:LandBuildings2024-04-30SC593120core:OtherPropertyPlantEquipment2024-04-30SC593120core:CurrentFinancialInstrumentscore:WithinOneYear2025-04-30SC593120core:CurrentFinancialInstrumentscore:WithinOneYear2024-04-30SC593120core:Non-currentFinancialInstrumentscore:AfterOneYear2025-04-30SC593120core:Non-currentFinancialInstrumentscore:AfterOneYear2024-04-30SC593120core:CurrentFinancialInstruments2025-04-30SC593120core:CurrentFinancialInstruments2024-04-30SC593120core:ShareCapital2025-04-30SC593120core:ShareCapital2024-04-30SC593120core:RetainedEarningsAccumulatedLosses2025-04-30SC593120core:RetainedEarningsAccumulatedLosses2024-04-30SC593120core:ShareCapitalOrdinaryShareClass12025-04-30SC593120core:ShareCapitalOrdinaryShareClass12024-04-30SC593120bus:Director12024-05-012025-04-30SC593120core:LeaseholdImprovements2024-05-012025-04-30SC593120core:PlantMachinery2024-05-012025-04-30SC593120core:FurnitureFittings2024-05-012025-04-30SC5931202023-05-012024-04-30SC593120core:LandBuildings2024-04-30SC593120core:OtherPropertyPlantEquipment2024-04-30SC5931202024-04-30SC593120core:LandBuildings2024-05-012025-04-30SC593120core:OtherPropertyPlantEquipment2024-05-012025-04-30SC593120core:Non-currentFinancialInstruments2025-04-30SC593120core:Non-currentFinancialInstruments2024-04-30SC593120bus:OrdinaryShareClass12024-05-012025-04-30SC593120bus:OrdinaryShareClass12025-04-30SC593120bus:OrdinaryShareClass12024-04-30SC593120bus:PrivateLimitedCompanyLtd2024-05-012025-04-30SC593120bus:SmallCompaniesRegimeForAccounts2024-05-012025-04-30SC593120bus:FRS1022024-05-012025-04-30SC593120bus:AuditExemptWithAccountantsReport2024-05-012025-04-30SC593120bus:FullAccounts2024-05-012025-04-30xbrli:purexbrli:sharesiso4217:GBP